BioXcel Therapeutics (BTAI) Earnings
|
Expand Research on BTAI
| Next EPS Date | 8/11/26 | EPS Growth Rate | +25.3% |
|---|---|---|---|
| Average EPS % Beat Rate | -144.3% | Revenue Growth Rate | -100.0% *Last Qtr. |
| Average % Move 1-Wk after EPS | -7.6% | Normal Earnings Time | N/A |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/11/26  |
Q226 | N/A | -$1.83 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/27/26 | Q425 | -$0.58 | $0.00 | -$0.58 | $260K | N/A | N/A |  | | Details | |
| 8/12/25 |
Q225 | N/A | -$0.13 | N/A | N/A | $400K | N/A | N/A | N/A | ||
| 8/12/25 | Q225 | -$2.45 | $0.00 | -$2.45 | $120K | N/A | N/A | | | Details | |
| 5/12/25 | Q125 | -$1.50 | -$0.21 | -$1.29 | $168K | $400K | N/A | | | Details | |
| 3/6/25 |
Q424 | N/A | -$0.46 | N/A | N/A | $689.23K | N/A | N/A | N/A | ||
| 11/14/24 | Q324 | -$0.32 | -$0.51 | +$0.19 | $210K | $1.33M | N/A | | | Details | |
| 8/6/24 | Q224 | -$0.21 | -$0.71 | +$0.50 | $1.1M | $662.5K | N/A | | | Details |
